/analysis/6231/
Market Focus
US stock advanced on Wednesday amid risk-on market sentiment, continuing to climb for a second day as investors considered that the pandemic of the Omicron coronavirus variant won’t derail the economic recovery. The FDA announced that it had approved Pfizer’s highly effective Covid-19 treatment pill for emergency use in the US . Moreover, three new studies showed that infection with Omicron is significantly less likely to result in hospitalisation. Therefore, market sentiment were improving as more and more evidence is indicating that the strain is potentially less severe than prior strains like Delta, which might give a boost to economic recovery in 2022. On top of that, some upbeat economic data also helped easing markets’ concerns about the epidemic, with US Existing Home Sales and Consumer Confidence both came in better-than-expected readings.
The benchmarks, S&P 500, Nasdaq 100 and the Dow Jones Industrial Average both rose on Wednesday as investors believe that Omicron variant would only have a temporary impact on the economic activity. US equity markets have maintained on Tuesday’s momentum. S&P 500 was up 1.0% on a daily basis and the Dow Jones Industrial Average also advanced with a 0.7% gain for the day. All eleven sectors stayed in positive territory as the consumer discreet and information technology sectors are the best performing among all groups, rising 1.73% and 1.33%, respectively. The Nasdaq 100 climbed the most with 1.2% gain on Wednesday and the MSCI World index rose 1.0%, while the S&P 500 CBOE volatility index dropped more than 1.50 and is now back below 20.00.
Main Pairs Movement:
The US dollar declined on Wednesday, staying in negative territory amid risk-on market mood and falling US bond yields. The DXY index reached a daily top during late Asian session, then pulled back to under 96.05 level to surrender most of its intraday’s gains. The positive news about the Omicron variant lend strong support to the stock markets and dampened the demand for the safe-haven greenback. The US FDA is now officially authorize the Paxlovid pill from Pfizer to treat high-risk patients.
GBP/USD advanced 0.66% on Wednesday amid renewed weakness saw in US dollar across the board. Investors’ optimism on the Omicron variant improved risk appetite and increased demand for risk-sensitive currencies like the British pounds. The cable touched a daily high above 1.335 level during American session, and the next strong resistance sits at 1.3374. Meanwhile, EUR/USD climbed to a daily top above 1.133 level but then retreated back to surrender some of its intraday’s gains. The pair gained 0.32% for the day.
Gold advanced and touched a daily top above $1804 in late American session, as the broad US dollar weakness keep investors using gold to hedge higher inflation. Meanwhile, WTI oil surged almost 2.5% for the day and climbed above $72.0 level, as the improving risk appetite and bullish inventory data both acted as a tailwind for the black gold. The US Crude Oil Inventories declined more than expected at over 4.7M barrels.
Technical Analysis:
Gold steadily holds below 1800 as a global rebound in stocks moderated, with the markets grappling with uncertainty over the new variant Omicron and an unclear economic outlook. From the technical aspect, the outlook of gold seems directionless on the 4- hour chart, looking to turn upside in the near- term as it is trading slightly above the 20 SMA as the tine of writing. As the RSI is slightly above 50th mark, gold’s bulls will attempt to test its psychological resistance at 1800 again. Further up, if buying resurgence above 1800 level, it will expose the opportunity to the upside toward 1815. On the flip side, a fresh downswing below the 20 SMA will turn gold to bearish in the near- term.
AAResistance: 1800, 1815, 1829
Support: 1782, 1770, 1765, 1753.
Bitcoin edges near 49500 ahead of Christmas holiday. Bitcoin seems to back in trend as the markets are back in green. From the technical perspective, the daily outlook of Bitcoin remains downside as it continues to trade within the lower bounce of Bollinger band, suggesting that selling pressure still exist despite the recent rise. Current support at 46510 becomes a critical and robust level for Bitcoin; if Bitcoin falls below 46510, then it will accelerate its bearish momentum and re- confirm its bearish mode. On the flip side, Bitcoin needs to climb above 55103, where the intersection of the resistance and the ascending line, in order to reclaim bullish stance. As the time of writing, the upside momentum has the opportunity to keep up as the RSI is well below overbought condition, giving rooms for Bitcoin to rise further north.
Resistance: 55103, 58000, 68991
AUDUSD attracts some buyers, pushing the price above 0.7219, ahead of US employment data. From the technical perspective, the 4- hour outlook remains bullish as it stays within the bearish channel. However, any subsequent move up is likely to face a stiff resistance at 0.7227, and it is challenging to break through as trading above 0.7227 will become a monthly high. In the meantime, if the currency can clear the resistance decisively, then it can see a fresh trigger for a bullish trend toward 0.7277. The upside momentum might pause before heading north as the RSI has reached nearly overbought, the momentum might limit.
Resistance: 0.7227, 0.7277
Support: 0.7170, 0.6997
Economic Data
Currency |
Data |
Time (GMT + 8) |
Forecast |
|
USD |
Core Durable Goods Orders (MoM) (Nov) |
21:30 |
0.6% |
|
USD |
Initial Jobless Claims |
21:30 |
205K |
|
CAD |
GDP (MoM) (Oct) |
21:30 |
0.1% |
|
USD |
New Home Sales (Nov) |
21:30 |
745K |
|
Education
Risk Warning: Trading CFDs carries a high level of risk and may not be suitable for all investors. Leverage in CFD trading can magnify gains and losses, potentially exceeding your original capital. It’s crucial to fully understand and acknowledge the associated risks before trading CFDs. Consider your financial situation, investment goals, and risk tolerance before making trading decisions. Past performance is not indicative of future results. Refer to our legal documents for a comprehensive understanding of CFD trading risks.
The information on this website is general and doesn’t account for your individual goals, financial situation, or needs. VT Markets cannot be held liable for the relevance, accuracy, timeliness, or completeness of any website information.
Our services and information on this website are not provided to residents of certain countries, including the United States, Singapore, Russia, and jurisdictions listed on the FATF and global sanctions lists. They are not intended for distribution or use in any location where such distribution or use would contravene local law or regulation.
VT Markets is a brand name with multiple entities authorised and registered in various jurisdictions.
· VT Global Pty Ltd is authorised and regulated by the Australian Securities & Investments Commission (ASIC) under licence number 516246.
· VT Global is not an issuer or market maker of derivatives and is only allowed to provide services to wholesale clients.
· VT Markets (Pty) Ltd is an authorised Financial Service Provider (FSP) registered and regulated by the Financial Sector Conduct Authority (FSCA) of South Africa under license number 50865.
· VT Markets Limited is an investment dealer authorised and regulated by the Mauritius Financial Services Commission (FSC) under license number GB23202269.
Copyright © 2024 VT Markets.